NEW YORK (360Dx) – Diagnostica Stago will distribute in the US Akers Biosciences' rapid test for heparin-induced thrombocytopenia (HIT) as part of deal announced today by the companies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.